Results 11 to 20 of about 57,565 (259)

Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG

Antioxidants, 2020
The expression of pluripotency factors is a key regulator of tumor differentiation status and cancer stem cells. The purpose of this study was to examine the expression of pluripotency factors and differentiation status of human mesothelioma and the role
Filip Sedlic, Fran Seiwerth, Ana Sepac, Suncana Sikiric, Marina Cindric, Marija Milavic, Lovorka Batelja Vuletic, Marko Jakopovic, Sven Seiwerth   +8 more
doaj   +1 more source

Understanding clinical decision-making in mesothelioma care: a mixed methods study

BMJ Open Respiratory Research, 2022
Introduction Malignant pleural mesothelioma is a rare, incurable cancer arising from previous asbestos exposure; patients have a poor prognosis, with a median survival rate of 8–14 months. Variation in mesothelioma clinical decision-making remains common
Najib Rahman, Catherine Henshall, Edward McKeown, Zoe Davey, Helen Walthall, Hannah Ball, Mitra Shahidi, John Park, Paul Dawson, Anand Sundralingam   +9 more
doaj   +1 more source

Mesothelioma in Scotland [PDF]

BMJ, 1970
In a retrospective study of the incidence of mesothelioma in Scotland for 1950-67 80 cases were traced from pathological reports and biopsy material of malignant tumours invading the pleura and peritoneum. These cases were matched with two sets of controls.
J, McEwen, A, Finlayson, A, Mair, A A, Gibson   +3 more
openaire   +2 more sources

Geographic distribution of malignant mesothelioma incidence and survival in Australia [PDF]

, 2022
Objectives: To understand the geographic distribution of and area-level factors associated with malignant mesothelioma incidence and survival in Australia.
Cameron, Jessica K., Mengersen, K, Baade, P, Mengersen, Kerrie, Aitken, J, Preston, P, Cameron, JK, Baade, Peter, Preston, Paige, Cramb, S, Armstrong, B, Reid, A, Reid, Alison, Aitken, Joanne, Armstrong, Bruce, Cramb, Susanna   +15 more
core   +1 more source

Meet the researchers: an alternative method of engaging patients with research in mesothelioma

Research Involvement and Engagement, 2018
Plain English summary There are new ways to engage people with science and research but many patient support groups and charitable organisations still hold traditional meetings to provide updates on their activities and to report new developments in ...
Kate Hill, Mags Portman, Zsuzsanna Tabi
doaj   +1 more source

Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. [PDF]

PLoS ONE, 2017
Malignant mesothelioma is a malignant tumor on the pleura or the peritoneum caused mostly by asbestos. Although asbestos is not currently used in South Korea, the incidence of mesothelioma is increasing due to its long latent period. This study predicted
Kyeong Min Kwak, Domyung Paek, Seung-Sik Hwang, Young-Su Ju   +3 more
doaj   +1 more source

The role of CD24 as a potential biomarker for malignant pleural mesothelioma

Egyptian Journal of Chest Disease and Tuberculosis, 2023
Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa, Ahmed Mamdooh Ghoname, Dalia Abd El-Kareem Ateya, Hamed A H Abdallah, Salwa Hassan Ahmed   +4 more
doaj   +1 more source

The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050 [PDF]

, 2005
The British mesothelioma register contains all deaths from 1968 to 2001 where mesothelioma was mentioned on the death certificate. These data were used to predict the future burden of mesothelioma mortality in Great Britain.
McElvenny, D, J T Hodgson, Peto, J, McElvenny, Damien, J Peto, Hodgson, John, Price, MJ, A J Darnton, Hodgson, JT, D M McElvenny, McElvenny, DM, Darnton, AJ, Price, Malcolm; id_orcid, M J Price   +13 more
core   +1 more source

Recommendations for improving follow-up care for patients with mesothelioma: a qualitative study comprising documentary analysis, interviews and consultation meetings

BMJ Open, 2021
Objectives The study aim was to explore experiences of patients with pleural mesothelioma of follow-up care in three National Health Service (NHS) Trusts to develop recommendations for practice.Design The study design was qualitative and comprised three ...
Najib Rahman, Catherine Henshall, Zoe Davey, Helen Walthall, Hannah Ball, Mitra Shahidi, John Park   +6 more
doaj   +1 more source

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. [PDF]

, 2011
BACKGROUND: The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed in a randomised trial.
Kilburn, L.S., Senan, S., Spicer, J., Coombes, G., Loic Lang-Lazdunski, O'Brien, M., Lang-Lazdunski, Loic, Treasure, T., Peto, Julian, Edwards, John, Michael Snee, Landau, David, David Waller, O'Byrne, Ken, Thomas, G., MARS trialists, O'Byrne, Kenneth J., Bliss, J.M., Landau, D., Tan, Carol, ?, ?, Entwisle, J., Liz Darlison, Kilburn, Lucy S, Edwards, J., Snee, M., Mary O'Brien, Peto, J., Waller, D., Spicer, James; id_orcid, Waller, David, Darlison, Liz, Gill Coombes, Darlison, L., Judith M Bliss, Suresh Senan, James Entwisle, Kilburn, Lucy S., Ken O'Byrne, Carol Tan, Bliss, Judith M., Treasure, Tom, O'Byrne, K., Snee, Michael, O'Brien, Mary, Lucy S Kilburn, Tom Treasure, Bliss, Judith M, Entwisle, James, John Edwards, David Landau, Senan, Suresh, James Spicer, Coombes, Gill, Tan, C., Gill Thomas, Spicer, James, Lang-Lazdunski, L., Julian Peto, Thomas, Gill   +59 more
core   +1 more source